Mycoplasmal and ureaplasmal infections

Infections of the Central Nervous System: Fourth Edition

Volumn , Issue , 2014, Pages

  Bitnun, Ari ^a,b   Richardson, Susan ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942144606     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (247)

1. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728, table of contents.
2. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18:757-789.
3. Heilmann C, Jensen L, Jensen JS, et al. Treatment of resistant Mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic. J Infect. 2001;43:234-238.
4. Sakata H, Hayashi T, Hirano Y, et al. Brain stem encephalitis due to Mycoplasma genitalium [in Japanese]. Kansenshogaku Zasshi. 1993;67: 500-504.
5. Orsted I, Gertsen JB, Schonheyder HC, et al. Mycoplasma salivarium isolated from brain abscesses. Clin Microbiol Infect. 2011;17:1047-1049.
6. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956-973.
7. Maniloff J. Phylogeny of mycoplasmas. In: Maniloff J, McElhaney R, Finch L, et al, eds. Mycoplasmas: Molecular Biology and Pathogenesis. Washington, DC: American Society of Microbiology; 1992:549-559.
8. Eaton MD, Meiklejohn G, van Herick W. Studies on the etiology of primary atypical pneumonia: a filterable agent transmissible to cotton rats, hamsters, and chick embryos. J Exp Med. 1944;79:649-668.
9. Chanock RM. Mycoplasma pneumoniae: proposed nomenclature for atypical pneumonia organism (Eaton agent). Science. 1963;140:662.
10. Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 2008;3:635-648.
11. Jordan JL, Chang HY, Balish MF, et al. Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium. Infect Immun. 2007;75:518-522.
12. Krunkosky TM, Jordan JL, Chambers E, et al. Mycoplasma pneumoniae host-pathogen studies in an air-liquid culture of differentiated human airway epithelial cells. Microb Pathog. 2007;42:98-103.
13. Yavlovich A, Tarshis M, Rottem S. Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells. FEMS Microbiol Lett. 2004;233:241-246.
14. Meseguer MA, Alvarez A, Rejas MT, et al. Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen. Infect Genet Evol. 2003;3:47-55.
15. Foy HM, Kenny GE, McMahan R, et al. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA. 1970;214:1666-1672.
16. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17(suppl 1): S37-S46.
17. Foy HM, Kenny GE, Cooney MK, et al. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis. 1979;139:681-687.
18. Feikin DR, Moroney JF, Talkington DF, et al. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario. Clin Infect Dis. 1999;29:1545-1550.
19. Mogabgab WJ. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966. Am Rev Respir Dis. 1968;97:345-358.
20. Foy HM, Grayston JT, Kenny GE, et al. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA. 1966;197:859-866.
21. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, et al. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis. 2001;183:675-678.
22. Yesnick L. Central nervous system complications of primary atypical pneumonia. AMA Arch Intern Med. 1956;97:93-98.
23. Ponka A. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis. 1980;12:175-184.
24. Sterner G, Biberfeld G. Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis. 1969;1:203-208.
25. Lind K, Zoffmann H, Larsen SO, et al. Mycoplasma pneumoniae infection associated with affection of the central nervous system. Acta Med Scand. 1979;205:325-332.
26. Tong CY, Menson E, Lin JP, et al. Prevalence of Mycoplasma encephalitis. Lancet Infect Dis. 2011;11:425-426.
27. Walter ND, Grant GB, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis. 2008;198:1365-1374.
28. Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis. 2001;32:1674-1784.
29. Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis. 1993;17(suppl 1):S52-S57.
30. Bitnun A, Richardson SE. Mycoplasma pneumoniae: innocent bystander or a true cause of central nervous system disease? Curr Infect Dis Rep. 2010;12:282-290.
31. Narita M. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr Neurol. 2009;41:159-166.
32. Jordan F. Avian mycoplasmas. In: Tully J, Whitcomb R, eds. The Mycoplasmas. New York: Academic Press; 1979:1-48.
33. Findlay G, Klieneberger E, Maccallum F, et al. Rolling disease: new syndrome in mice associated with pleuropulmonary-like organism. Lancet. 1938;2:1511-1153.
34. Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am Rev Respir Dis. 1980;122:491-496.
35. Launes J, Paetau A, Linnavuori K, et al. Direct invasion of the brain parenchyma by Mycoplasma pneumoniae. Acta Neurol Scand. 1997;95:374.
36. Stamm B, Moschopulos M, Hungerbuehler H, et al. Neuroinvasion by Mycoplasma pneumoniae in acute disseminated encephalomyelitis. Emerg Infect Dis. 2008;14(4):641-643.
37. Powers JM, Johnson MD. Mycoplasmal panencephalitis: a neuropathologic documentation. Acta Neuropathol. 2012;124:143-148.
38. Abele-Horn M, Franck W, Busch U, et al. Transverse myelitis associated with Mycoplasma pneumoniae infection. Clin Infect Dis. 1998;26:909-912.
39. Abramovitz P, Schvartzman P, Harel D, et al. Direct invasion of the central nervous system by Mycoplasma pneumoniae: a report of two cases. J Infect Dis. 1987;155:482-487.
40. Christie LJ, Honarmand S, Talkington DF, et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics. 2007;120:305-313.
41. Dionisio D, Valassina M, Mata S, et al. Encephalitis caused directly by Mycoplasma pneumoniae. Scand J Infect Dis. 1999;31:506-509.
42. Goebels N, Helmchen C, Abele-Horn M, et al. Extensive myelitis associated with Mycoplasma pneumoniae infection: magnetic resonance imaging and clinical long-term follow-up. J Neurol. 2001;248:204-208.
43. Inoue S, Ohfu M, Morooka T, et al. A case of encephalitis due to Mycoplasma pneumoniae: detection of specific DNA from cerebrospinal fluid and elevation of interleukin-6 [in Japanese]. Kansenshogaku Zasshi. 1998;72:771-775.
44. Kasahara I, Otsubo Y, Yanase T, et al. Isolation and characterization of Mycoplasma pneumoniae from cerebrospinal fluid of a patient with pneumonia and meningoencephalitis. J Infect Dis. 1985;152:823-825.
45. Lin WC, Lee PI, Lu CY, et al. Mycoplasma pneumoniae encephalitis in childhood. J Microbiol Immunol Infect. 2002;35:173-178.
46. Matsumoto N, Takahashi S, Toriumi N, et al. Acute disseminated encephalomyelitis in an infant with incontinentia pigmenti. Brain Dev. 2009;31: 625-628.
47. Nagayama Y, Sakurai N, Tamai K, et al. Isolation of Mycoplasma pneumoniae from pleural fluid and/or cerebrospinal fluid: report of four cases. Scand J Infect Dis. 1987;19:521-524.
48. Narita M, Itakura O, Matsuzono Y, et al. Analysis of mycoplasmal central nervous system involvement by polymerase chain reaction. Pediatr Infect Dis J. 1995;14:236-237.
49. Narita M, Matsuzono Y, Itakura O, et al. Survey of mycoplasmal bacteremia detected in children by polymerase chain reaction. Clin Infect Dis. 1996;23:522-525.
50. Padovan CS, Pfister HW, Bense S, et al. Detection of Mycoplasma pneumoniae DNA in cerebrospinal fluid of a patient with M. pneumoniae infection-"associated" stroke. Clin Infect Dis. 2001;33:E119-E121.
51. Riedel K, Kempf VA, Bechtold A, et al. Acute disseminated encephalomyelitis (ADEM) due to Mycoplasma pneumoniae infection in an adolescent. Infection. 2001;29:240-242.
52. Socan M, Ravnik I, Bencina D, et al. Neurological symptoms in patients whose cerebrospinal fluid is culture-and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis. 2001;32:E31-E35.
53. Tjhie JH, van de Putte EM, Haasnoot K, et al. Fatal encephalitis caused by Mycoplasma pneumoniae in a 9-year-old girl. Scand J Infect Dis. 1997;29:424-425.
54. Rhodes RH, Monastersky BT, Tyagi R, et al. Mycoplasmal cerebral vasculopathy in a lymphoma patient: presumptive evidence of Mycoplasma pneumoniae microvascular endothelial cell invasion in a brain biopsy. J Neurol Sci. 2011;309:18-25.
55. Zu-Rhein GM, Powers JM. Correspondence regarding: a novel microangiopathy with endothelial cell atypia and multifocal white matter lesions: a direct mycopasmal infection? J Neuropathol Exp Neurol. 2011;70:1151.
56. Chin RP, Daft BM, Meteyer CU, et al. Meningoencephalitis in commercial meat turkeys associated with Mycoplasma gallisepticum. Avian Dis. 1991;35:986-993.
57. Hill A. Mycoplasma pulmonis infection in the brains of rodents. J Infect Dis. 1983;147:540-555.
58. Brown DR, Nogueira MF, Schoeb TR, et al. Pathology of experimental mycoplasmosis in American alligators. J Wildl Dis. 2001;37:671-679.
59. Susuki K, Odaka M, Mori M, et al. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology. 2004;62:949-956.
60. Kusunoki S, Shiina M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to Mycoplasma infection: evidence of molecular mimicry. Neurology. 2001;57:736-738.
61. Nishimura M, Saida T, Kuroki S, et al. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J Neurol Sci. 1996;140:91-95.
62. Kusunoki S, Chiba A, Hitoshi S, et al. Anti-Gal-C antibody in autoimmune neuropathies subsequent to Mycoplasma infection. Muscle Nerve. 1995;18:409-413.
63. Ang CW, Tio-Gillen AP, Groen J, et al. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barre syndrome. J Neuroimmunol. 2002;130:179-183.
64. Christie LJ, Honarmand S, Yagi S, et al. Anti-galactocerebroside testing in Mycoplasma pneumoniae-associated encephalitis. J Neuroimmunol. 2007;189:129-131.
65. Narita M, Tanaka H, Togashi T, et al. Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae. Pediatr Neurol. 2005;33:105-109.
66. Fu M, Wong KS, Lam WW, et al. Middle cerebral artery occlusion after recent Mycoplasma pneumoniae infection. J Neurol Sci. 1998;157:113-115.
67. Mulder LJ, Spierings EL. Stroke in a young adult with Mycoplasma pneumoniae infection complicated by intravascular coagulation. Neurology. 1987;37:1430-1431.
68. Ode B, Cronberg S. Infection and intracranial arterial thrombosis. Lancet. 1976;2:863-864.
69. Ryu JS, Kim HJ, Sung IY, et al. Posterior cerebral artery occlusion after Mycoplasma pneumoniae infection associated with genetic defect of MTHFR C677T. J Child Neurol. 2009;24:891-894.
70. Senda J, Ito M, Atsuta N, et al. Paradoxical brain embolism induced by Mycoplasma pneumoniae infection with deep venous thrombus. Intern Med. 2010;49:2003-2005.
71. Ovetchkine P, Brugieres P, Seradj A, et al. An 8-y-old boy with acute stroke and radiological signs of cerebral vasculitis after recent Mycoplasma pneumoniae infection. Scand J Infect Dis. 2002;34:307-309.
72. Perez C, Montes M. Cutaneous leukocytoclastic vasculitis and encephalitis associated with Mycoplasma pneumoniae infection. Arch Intern Med. 2002;162:352-354.
73. Sanchez-Vargas FM, Gomez-Duarte OG. Mycoplasma pneumoniae-an emerging extra-pulmonary pathogen. Clin Microbiol Infect. 2008;14:105-117.
74. Levy M, Shear NH. Mycoplasma pneumoniae infections and Stevens-Johnson syndrome. Report of eight cases and review of the literature. Clin Pediatr. 1991;30:42-49.
75. Schalock PC, Dinulos JG. Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction? J Am Acad Dermatol. 2005;52:312-315.
76. Lyell A, Gordon AM, Dick HM, et al. Mycoplasmas and erythema multiforme. Lancet. 1967;2:1116-1118.
77. O'Sullivan MV, Isbel NM, Johnson DW, et al. Disseminated pyogenic Mycoplasma pneumoniae infection in a renal transplant recipient, detected by broad-range polymerase chain reaction. Clin Infect Dis. 2004;39: e98-e99.
78. Roifman CM, Rao CP, Lederman HM, et al. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986;80:590-594.
79. Lehtokoski-Lehtiniemi E, Koskiniemi ML. Mycoplasma pneumoniae encephalitis: a severe entity in children. Pediatr Infect Dis J. 1989;8: 651-653.
80. Domenech C, Leveque N, Lina B, et al. Role of Mycoplasma pneumoniae in pediatric encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:91-94.
81. Daxboeck F, Blacky A, Seidl R, et al. Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases. J Child Neurol. 2004;19:865-871.
82. Heatwole CR, Berg MJ, Henry JC, et al. Extreme spindles: a distinctive EEG pattern in Mycoplasma pneumoniae encephalitis. Neurology. 2005;64:1096-1097.
83. Thomas NH, Collins JE, Robb SA, et al. Mycoplasma pneumoniae infection and neurological disease. Arch Dis Child. 1993;69:573-576.
84. Rautonen J, Koskiniemi M, Vaheri A. Prognostic factors in childhood acute encephalitis. Pediatr Infect Dis J. 1991;10:441-446.
85. Suzuki K, Matsubara S, Uchikata M, et al. A case of Mycoplasma pneumoniae pneumonia associated with meningoencephalitis [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi. 1982;20:1084-1089.
86. Narita M, Matsuzono Y, Togashi T, et al. DNA diagnosis of central nervous system infection by Mycoplasma pneumoniae. Pediatrics. 1992;90: 250-253.
87. Ieven M, Demey H, Ursi D, et al. Fatal encephalitis caused by Mycoplasma pneumoniae diagnosed by the polymerase chain reaction. Clin Infect Dis. 1998;27:1552-1553.
88. Lerer RJ, Kalavsky SM. Central nervous system disease associated with Mycoplasma pneumoniae infection: report of five cases and review of the literature. Pediatrics. 1973;52:658-668.
89. Dorff B, Lind K. Two fatal cases of meningoencephalitis associated with Mycoplasma pneumoniae infection. Scand J Infect Dis. 1976;8:49-51.
90. Weinblatt ME, Caplan ES. Fatal Mycoplasma pneumoniae encephalitis in an adult. Arch Neurol. 1980;37:321.
91. Koskiniemi M, Vaheri A. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet. 1989;1:31-34.
92. Bruch LA, Jefferson RJ, Pike MG, et al. Mycoplasma pneumoniae infection, meningoencephalitis, and hemophagocytosis. Pediatr Neurol. 2001;25:67-70.
93. Hulihan JF, Bebin EM, Westmoreland BF. Bilateral periodic lateralized epileptiform discharges in Mycoplasma encephalitis. Pediatr Neurol. 1992;8:292-294.
94. Hodges GR, Fass RJ, Saslaw S. Central nervous system disease associated with Mycoplasma pneumoniae infection. Arch Intern Med. 1972;130:277-282.
95. Fernandez CV, Bortolussi R, Gordon K, et al. Mycoplasma pneumoniae infection associated with central nervous system complications. J Child Neurol. 1993;8:27-31.
96. Kumar RK. Mycoplasma encephalitis-should we be thinking more about it? J Paediatr Child Health. 1998;34:305.
97. de Lalibera IB, Silveira Gde A, Toma RK, et al. Meningoencephalitis associated with Mycoplasma pneumoniae. Einstein (Sao Paulo). 2012;10: 100-102.
98. Simpkins A, Strickland SM, Oliver J, et al. Complete resolution of advanced Mycoplasma pneumoniae encephalitis mimicking brain mass lesions: report of two pediatric cases and review of literature. Neuropathology. 2012;32:91-99.
99. Lin JJ, Lin KL, Chiu CH, et al. Antineuronal antibodies and infectious pathogens in severe acute pediatric encephalitis [published online ahead of print November 8, 2012]. J Child Neurol.
100. Esposito S, Tagliabue C, Bosis S, et al. Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood. Int J Antimicrob Agents. 2011;37:472-475.
101. Carpenter TC. Corticosteroids in the treatment of severe Mycoplasma encephalitis in children. Crit Care Med. 2002;30:925-927.
102. Cano-Sanchez A, Cano-Gracia H, Fernandez-Pardo J, et al. Aseptic meningitis caused by Mycoplasma pneumoniae in a 19-year-old woman. Eur J Clin Microbiol Infect Dis. 1999;18:228-229.
103. Gupta A, Kimber T, Crompton JL, et al. Acute disseminated encephalomyelitis secondary to Mycoplasma pneumoniae. Intern Med J. 2009;39:68-69.
104. Tan MJ, Chattophadyay AK, Griffiths PD, et al. Acute central and peripheral demyelination associated with Mycoplasma pneumoniae. Pediatr Neurol. 2003;29:239-241.
105. Kumada S, Kusaka H, Okaniwa M, et al. Encephalomyelitis subsequent to Mycoplasma infection with elevated serum anti-Gal C antibody. Pediatr Neurol. 1997;16:241-244.
106. Kornips HM, Verhagen WI, Prick MJ. Acute disseminated encephalomyelitis probably related to a Mycoplasma pneumoniae infection. Clin Neurol Neurosurg. 1993;95:59-63.
107. Fisher RS, Clark AW, Wolinsky JS, et al. Postinfectious leukoencephalitis complicating Mycoplasma pneumoniae infection. Arch Neurol. 1983;40:109-113.
108. Bouziri A, Khaldi A, Menif K, et al. Acute disseminated encephalomyelitis associated with Mycoplasma pneumoniae infection in children: 2 case reports [in French]. Tunis Med. 2010;88:125-128.
109. Hagiwara H, Sakamoto S, Katsumata T, et al. Acute disseminated encephalomyelitis developed after Mycoplasma pneumoniae infection complicating subclinical measles infection. Intern Med. 2009;48:479-483.
110. Aydin A, Atasever S, Cakmakci H. Acute disseminated encephalomyelitis presenting with bilateral transient amaurosis. Pediatr Neurol. 2005;32:60-63.
111. Tsiodras S, Kelesidis T, Kelesidis I, et al. Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Eur J Neurol. 2006;13: 112-124.
112. Behan PO, Feldman RG, Segerra JM, et al. Neurological aspects of mycoplasmal infection. Acta Neurol Scand. 1986;74:314-322.
113. Pellegrini M, O'Brien TJ, Hoy J, et al. Mycoplasma pneumoniae infection associated with an acute brainstem syndrome. Acta Neurol Scand. 1996;93:203-206.
114. Pfausler B, Engelhardt K, Kampfl A, et al. Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature. Eur J Neurol. 2002;9:93-96.
115. Ryan LJ, Bowman R, Zantek ND, et al. Use of therapeutic plasma exchange in the management of acute hemorrhagic leukoencephalitis: a case report and review of the literature. Transfusion. 2007;47:981-986.
116. Catalan M, Naccarato M, Grandi FC, et al. Acute hemorrhagic leukoencephalitis with atypical features. Neurol Sci. 2009;30:55-57.
117. Renault F, Arzimanoglou A, Rancurel G, et al. Hurst-type acute leukoencephalitis with complete recovery in a child [in French]. Presse Med. 1985;14:1959-1961.
118. Tezer H, Kara A, Haliloglu G, et al. Mycoplasma pneumoniae-associated transverse myelitis with unexpected rapid response to macrolide therapy: a case report. Turk J Pediatr. 2008;50:585-588.
119. Yis U, Kurul SH, Cakmakci H, et al. Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr. 2008;167:973-978.
120. Weng WC, Peng SS, Wang SB, et al. Mycoplasma pneumoniae-associated transverse myelitis and rhabdomyolysis. Pediatr Neurol. 2009;40:128-130.
121. Steer AC, Starr M, Kornberg AJ. Bickerstaff brainstem encephalitis associated with Mycoplasma pneumoniae infection. J Child Neurol. 2006;21:533-534.
122. Kikuchi M, Tagawa Y, Iwamoto H, et al. Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy. J Child Neurol. 1997;12:403-405.
123. Saitoh S, Wada T, Narita M, et al. Mycoplasma pneumoniae infection may cause striatal lesions leading to acute neurologic dysfunction. Neurology. 1993;43:2150-2151.
124. Sakoulas G. Brainstem and striatal encephalitis complicating Mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulin. Pediatr Infect Dis J. 2001;20:543-545.
125. Al-Mateen M, Gibbs M, Dietrich R, et al. Encephalitis lethargica-like illness in a girl with Mycoplasma infection. Neurology. 1988;38: 1155-1158.
126. Sasaki M, Matsuda H, Omura I, et al. Transient seizure disappearance due to bilateral striatal necrosis in a patient with intractable epilepsy. Brain Dev. 2000;22:50-55.
127. Donovan MK, Lenn NJ. Postinfectious encephalomyelitis with localized basal ganglia involvement. Pediatr Neurol. 1989;5:311-313.
128. Kim JS, Choi IS, Lee MC. Reversible parkinsonism and dystonia following probable Mycoplasma pneumoniae infection. Mov Disord. 1995;10: 510-512.
129. Green C, Riley DE. Treatment of dystonia in striatal necrosis caused by Mycoplasma pneumoniae. Pediatr Neurol. 2002;26:318-320.
130. Larsen PD, Crisp D. Acute bilateral striatal necrosis associated with Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 1996;15: 1124-1126.
131. van Buiren M, Uhl M. Images in clinical medicine. Bilateral striatal necrosis associated with Mycoplasma pneumoniae infection. N Engl J Med. 2003;348:720.
132. Termine C, Uggetti C, Veggiotti P, et al. Long-term follow-up of an adolescent who had bilateral striatal necrosis secondary to Mycoplasma pneumoniae infection. Brain Dev. 2005;27:62-65.
133. Okumura K, Aizaki K, Tsuru T. Case of acute brainstem and striatal encephalopathy associated with Mycoplasma pneumoniae infection [in Japanese]. No To Hattatsu. 2011;43:471-475.
134. El Hafidi N, Allouch B, Benbrahim F, et al. Mycoplasma pneumoniae encephalitis associated with basal ganglia necrosis [in French]. Rev Neurol. 2012;168:49-52.
135. Coon EA, Patterson MC. Teaching neuroimages: call it as you see it: evolution of bilateral striatal necrosis. Neurology. 2012;78:e123.
136. Fusco C, Bonini E, Soncini G, et al. Transient basal ganglia and thalamic involvement following Mycoplasma pneumoniae infection associated with antiganglioside antibodies. J Child Neurol. 2010;25:1029-33.
137. Zambrino CA, Zorzi G, Lanzi G, et al. Bilateral striatal necrosis associated with Mycoplasma pneumoniae infection in an adolescent: clinical and neuroradiologic follow up. Mov Disord. 2000;15:1023-1026.
138. Noseda G, Harpey JP, Brandel JP, et al. Acute basal ganglia necrosis with favorable course during Mycoplasma encephalitis [in French]. Arch Pediatr. 1996;3:1107-1110.
139. Brandel JP, Vidailhet M, Noseda G, et al. Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis. Mov Disord. 1996;11:333-336.
140. Mariotti P, Nociti V, Stefanini MC, et al. Pneumonia's link with the head and heart. Lancet. 2010;376:388.
141. Ashtekar CS, Jaspan T, Thomas D, et al. Acute bilateral thalamic necrosis in a child with Mycoplasma pneumoniae. Dev Med Child Neurol. 2003;45:634-637.
142. Wang HS. "Acute bilateral thalamic necrosis in a child with Mycoplasma pneumoniae." Dev Med Child Neurol. 2004;46:214; author reply 214-215.
143. Neilson DE, Adams MD, Orr CM, et al. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84:44-51.
144. Chemli J, Ketata S, Dalhoumi A, et al. Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection [in French]. Arch Pediatr. 2007;14:1003-1006.
145. Huber BM, Strozzi S, Steinlin M, et al. Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases. Eur J Pediatr. 2010;169:441-445.
146. Mesraoua B, Abbas M, D'Souza A, et al. Adult opsoclonus-myoclonus syndrome following Mycoplasma pneumoniae infection with dramatic response to plasmapheresis. Acta Neurol Belg. 2011;111:136-138.
147. Nunes JC, Bruscato AM, Walz R, et al. Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection in an elderly patient. J Neurol Sci. 2011;305:147-148.
148. Shiihara T, Takahashi Y. Correspondence: a further case of opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection. Eur J Pediatr. 2010;169:639; author reply 641.
149. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366:1653-1666.
150. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51:1110-1115.
151. Schessl J, Luther B, Kirschner J, et al. Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study. Eur J Pediatr. 2006;165:605-612.
152. Sinha S, Prasad KN, Jain D, et al. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study. Clin Microbiol Infect. 2007;13:334-337.
153. Fleischhauer P, Huben U, Mertens H, et al. Demonstration of Mycoplasma pneumoniae in cerebrospinal fluid in acute polyneuritis [in German]. Dtsch Med Wochenschr. 1972;97:678-682.
154. Ponka A, von Bonsdorff M, Farkkila M. Polyradiculitis associated with Mycoplasma pneumoniae reversed by plasma exchange. Br Med J (Clin Res Ed). 1983;286:475-476.
155. Meseguer MA, Aparicio M, Calvo A, et al. Mycoplasma pneumoniae antigen detection in Guillain-Barré syndrome. Eur J Pediatr. 1998;157:1034.
156. Lacroix LE, Galetto A, Haenggeli CA, et al. Delayed recognition of Guillain-Barré syndrome in a child: a misleading respiratory distress. J Emerg Med. 2010;38:e59-e61.
157. Arakawa H, Yuhara Y, Todokoro M, et al. Immunoadsorption therapy for a child with Guillain-Barré syndrome subsequent to Mycoplasma infection: a case study. Brain Dev. 2005;27:431-433.
158. Steele JC, Gladstone RM, Thanasophon S, et al. Acute cerebellar ataxia and concomitant infection with Mycoplasma pneumoniae. J Pediatr. 1972;80:467-469.
159. Coleman RJ, Brown JS, Butler P, et al. Cerebellar syndrome with hydrocephalus due to Mycoplasma pneumoniae infection. Postgrad Med J. 1990;66:554-556.
160. Leonardi S, Pavone P, Rotolo N, et al. Stroke in two children with Mycoplasma pneumoniae infection. A causal or casual relationship? Pediatr Infect Dis J. 2005;24:843-845.
161. Parker P, Puck J, Fernandez F. Cerebral infarction associated with Mycoplasma pneumoniae. Pediatrics. 1981;67:373-375.
162. Visudhiphan P, Chiemchanya S, Sirinavin S. Internal carotid artery occlusion associated with Mycoplasma pneumoniae infection. Pediatr Neurol. 1992;8:237-239.
163. Lee CY, Huang YY, Huang FL, et al. Mycoplasma pneumoniae-associated cerebral infarction in a child. J Trop Pediatr. 2009;55:272-275.
164. Dowd AB, Grace R, Rees WD. Cerebral infarction associated with Mycoplasma pneumoniae infection. Lancet. 1987;2:567.
165. Zu-Rhein GM, Lo SC, Hulette CM, et al. A novel cerebral microangiopathy with endothelial cell atypia and multifocal white matter lesions: a direct mycoplasmal infection? J Neuropathol Exp Neurol. 2007;66:1100-1117.
166. Arthur G, Margolis G. Mycoplasma-like structures in granulomatous angiitis of the central nervous system. Case reports with light and electron microscopic studies. Arch Pathol Lab Med. 1977;101:382-387.
167. Jacobs E. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infect Dis. 1993;17(suppl 1): S79-S82.
168. Schwartz SB, Zhang M, Thacker WL, et al. Mycoplasma pneumoniae in encephalitis. In: 100th Meeting of the American Society of Microbiology. Chicago: ASM; 1999.
169. Biberfeld G, Sterner G. A study of Mycoplasma pneumoniae infections in families. Scand J Infect Dis. 1969;1:39-46.
170. Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008;8:93.
171. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244-1249.
172. Waites KB, Thacker WL, Talkington DF. The value of culture and serology for the detection of Mycoplasma pneumoniae infections in the clinical laboratory in the age of molecular diagnostics. Clin Microbiol Newsl. 2001;23:123-129.
173. Kenny GE, Kaiser GG, Cooney MK, et al. Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J Clin Microbiol. 1990;28:2087-2093.
174. Montagnani F, De Paolis F, Beghetto E, et al. Use of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis. 2010;29:1377-1386.
175. Tabassum I, Chaudhry R, Chourasia BK, et al. Identification of an N-terminal 27 kDa fragment of Mycoplasma pneumoniae P116 protein as specific immunogen in M. pneumoniae infections. BMC Infect Dis. 2010;10:350.
176. Beersma MF, Dirven K, van Dam AP, et al. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard." J Clin Microbiol. 2005;43:2277-2285.
177. Tsiodras S, Kelesidis I, Kelesidis T, et al. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect. 2005;51: 343-354.
178. Bitnun A, Ford-Jones E, Blaser S, et al. Mycoplasma pneumoniae ecephalitis. Semin Pediatr Infect Dis. 2003;14:96-107.
179. Schwab S, Junger E, Spranger M, et al. Craniectomy: an aggressive treatment approach in severe encephalitis. Neurology. 1997;48:412-417.
180. Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, et al. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother. 1996;40:825-826.
181. Lutsar I, McCracken GH Jr, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis. 1998;27:1117-1127, quiz 1128-1129.
182. Wolff M, Boutron L, Singlas E, et al. Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. Antimicrob Agents Chemother. 1987;31:899-902.
183. Yim CW, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother. 1985;28:347-348.
184. Kramer PW, Griffith RS, Campbell RL. Antibiotic penetration of the brain. A comparative study. J Neurosurg. 1969;31:295-302.
185. Hsing J, Welgampola M, Kiernan MC. Reversible myeloradiculopathy due to Mycoplasma pneumoniae. J Clin Neurosci. 2007;14:61-64.
186. Csabi G, Komaromy H, Hollody K. Transverse myelitis as a rare, serious complication of Mycoplasma pneumoniae infection. Pediatr Neurol. 2009;41:312-313.
187. Ginestal RC, Plaza JF, Callejo JM, et al. Bilateral optic neuritis and Guillain-Barre syndrome following an acute Mycoplasma pneumoniae infection. J Neurol. 2004;251:767-768.
188. Robertson JA, Stemke GW, Davis JW Jr, et al. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol. 2002;52:587-597.
189. Waites KB, Schelonka RL, Xiao L, et al. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonatal Med. 2009;14:190-199.
190. Al Masalma M, Armougom F, Scheld WM, et al. The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clin Infect Dis. 2009;48:1169-1178.
191. Al Masalma M, Lonjon M, Richet H, et al. Metagenomic analysis of brain abscesses identifies specific bacterial associations. Clin Infect Dis. 2012;54:202-210.
192. Madoff S, Hooper DC. Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis. 1988;10:602-613.
193. Hata A, Honda Y, Asada K, et al. Mycoplasma hominis meningitis in a neonate: case report and review. J Infect. 2008;57:338-343.
194. Alonso-Vega C, Wauters N, Vermeylen D, et al. A fatal case of Mycoplasma hominis meningoencephalitis in a full-term newborn. J Clin Microbiol. 1997;35:286-287.
195. Gewitz M, Dinwiddie R, Rees L, et al. Mycoplasma hominis. A cause of neonatal meningitis. Arch Dis Child. 1979;54:231-233.
196. Hjelm E, Jonsell G, Linglof T, et al. Meningitis in a newborn infant caused by Mycoplasma hominis. Acta Paediatr Scand. 1980;69:415-418.
197. Kirk N, Kovar I. Mycoplasma hominis meningitis in a preterm infant. J Infect. 1987;15:109-110.
198. Knausz M, Niederland T, Dosa E, et al. Meningo-encephalitis in a neonate caused by maternal Mycoplasma hominis treated successfully with chloramphenicol. J Med Microbiol. 2002;51:187-188.
199. McDonald JC, Moore DL. Mycoplasma hominis meningitis in a premature infant. Pediatr Infect Dis J. 1988;7:795-798.
200. Waites KB, Duffy LB, Crouse DT, et al. Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J. 1990;9:241-245.
201. Waites KB, Rudd PT, Crouse DT, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet. 1988;1:17-21.
202. Watt KM, Massaro MM, Smith B, et al. Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis. Pediatr Infect Dis J. 2012;31:197-199.
203. Wealthall SR. Mycoplasma meningitis in infants with spina bifida. Dev Med Child Neurol Suppl. 1975:117-122.
204. Wolthers KC, Kornelisse RF, Platenkamp GJ, et al. A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacin. Eur J Pediatr. 2003;162: 514-516.
205. Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis. 1993;17(suppl. 1): S243-S249.
206. McCarthy KL, Looke DF. Successful treatment of post-neurosurgical intracranial Mycoplasma hominis infection using gatifloxacin. J Infect. 2008;57:344-346.
207. Chong JS, Tseung SY, Lam HS, et al. Successful treatment of multiple subdural empyemata caused by Mycoplasma hominis in a newborn. Neonatology. 2009;95:179-182.
208. Rao RP, Ghanayem NS, Kaufman BA, et al. Mycoplasma hominis and Ureaplasma species brain abscess in a neonate. Pediatr Infect Dis J. 2002;21:1083-1085.
209. Siber GR, Alpert S, Smith AL, et al. Neonatal central nervous system infection due to Mycoplasma hominis. J Pediatr. 1977;90:625-627.
210. Biran V, Dumitrescu AM, Doit C, et al. Ureaplasma parvum meningitis in a full-term newborn. Pediatr Infect Dis J. 2010;29:1154.
211. Chung HY, Chung JW, Chun SH, et al. A case of erythromycin-resistant Ureaplasma urealyticum meningitis in a premature infant [in Korean]. Korean J Lab Med. 2007;27:46-49.
212. Clifford V, Tebruegge M, Everest N, et al. Ureaplasma: pathogen or passenger in neonatal meningitis? Pediatr Infect Dis J. 2010;29:60-64.
213. Hentschel J, Abele-Horn M, Peters J. Ureaplasma urealyticum in the cerebrospinal fluid of a premature infant. Acta Paediatr. 1993;82:690-693.
214. Neal TJ, Roe MF, Shaw NJ. Spontaneously resolving Ureaplasma urealyticum meningitis. Eur J Pediatr. 1994;153:342-343.
215. Ollikainen J, Hiekkaniemi H, Korppi M, et al. Ureaplasma urealyticum cultured from brain tissue of preterm twins who died of intraventricular hemorrhage. Scand J Infect Dis. 1993;25:529-531.
216. Ollikainen J, Hiekkaniemi H, Korppi M, et al. Ureaplasma urealyticum infection associated with acute respiratory insufficiency and death in premature infants. J Pediatr. 1993;122:756-760.
217. Sethi S, Sharma M, Narang A, et al. Isolation pattern and clinical outcome of genital Mycoplasma in neonates from a tertiary care neonatal unit. J Trop Pediatr. 1999;45:143-145.
218. Shaw NJ, Pratt BC, Weindling AM. Ureaplasma and Mycoplasma infections of the central nervous system in preterm infants. Lancet. 1989;2:1530-1531.
219. Stahelin-Massik J, Levy F, Friderich P, et al. Meningitis caused by Ureaplasma urealyticum in a full term neonate. Pediatr Infect Dis J. 1994;13:419-421.
220. Viscardi RM, Hashmi N, Gross GW, et al. Incidence of invasive ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage. J Perinatol. 2008;28:759-765.
221. Geissdorfer W, Sandner G, John S, et al. Ureaplasma urealyticum meningitis in an adult patient. J Clin Microbiol. 2008;46:1141-1143.
222. McCormack WM, Almeida PC, Bailey PE, et al. Sexual activity and vaginal colonization with genital mycoplasmas. JAMA. 1972;221:1375-1377.
223. McCormack WM, Lee YH, Zinner SH. Sexual experience and urethral colonization with genital mycoplasmas. A study in normal men. Ann Intern Med. 1973;78:696-698.
224. Tully JG, Taylor-Robinson D, Rose DL, et al. Evaluation of culture media for the recovery of Mycoplasma hominis from the human urogenital tract. Sex Transm Dis. 1983;10:256-260.
225. Keane FE, Thomas BJ, Gilroy CB, et al. The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners. Int J STD AIDS. 2000;11:356-360.
226. Schlicht MJ, Lovrich SD, Sartin JS, et al. High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin. J Clin Microbiol. 2004;42: 4636-4640.
227. Grattard F, Soleihac B, De Barbeyrac B, et al. Epidemiologic and molecular investigations of genital mycoplasmas from women and neonates at delivery. Pediatr Infect Dis J. 1995;14:853-858.
228. Foy HM, Kenny GE, Levinsohn EM, et al. Acquisition of mycoplasmata and T-strains during infancy. J Infect Dis. 1970;121:579-587.
229. Hammerschlag MR, Alpert S, Rosner I, et al. Microbiology of the vagina in children: normal and potentially pathogenic organisms. Pediatrics. 1978;62:57-62.
230. Foy H, Kenny G, Bor E, et al. Prevalence of Mycoplasma hominis and Ureaplasma urealyticum (T strains) in urine of adolescents. J Clin Microbiol. 1975;2:226-230.
231. Petrikkos GL, Hadjisoteriou M, Daikos GL. PCR versus culture in the detection of vaginal Ureaplasma urealyticum and Mycoplasma hominis. Int J Gynaecol Obstet. 2007;97:202-203.
232. Ferandon C, Peuchant O, Janis C, et al. Development of a real-time PCR targeting the yidC gene for the detection of Mycoplasma hominis and comparison with quantitative culture. Clin Microbiol Infect. 2011;17: 155-159.
233. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother. 2001;45:2604-2608.
234. Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010;16:1649-1655.
235. Sanchez PJ, Regan JA. Vertical transmission of Ureaplasma urealyticum in full term infants. Pediatr Infect Dis J. 1987;6:825-828.
236. Sanchez PJ, Regan JA. Vertical transmission of Ureaplasma urealyticum from mothers to preterm infants. Pediatr Infect Dis J. 1990;9: 398-401.
237. Syrogiannopoulos GA, Kapatais-Zoumbos K, Decavalas GO, et al. Ureaplasma urealyticum colonization of full term infants: perinatal acquisition and persistence during early infancy. Pediatr Infect Dis J. 1990;9: 236-240.
238. Volgmann T, Ohlinger R, Panzig B. Ureaplasma urealyticum-harmless commensal or underestimated enemy of human reproduction? A review. Arch Gynecol Obstet. 2005;273:133-139.
239. Viscardi RM. Ureaplasma species: role in diseases of prematurity. Clin Perinatol. 2010;37:393-409.
240. Lucke K, Kuster SP, Bertea M, et al. A deep sternal wound infection caused by Ureaplasma urealyticum. J Med Microbiol. 2010;59:1254-1256.
241. Skoldenberg OG, Rysinska AD, Neander G, et al. Ureaplasma urealyticum infection in total hip arthroplasty leading to revision. J Arthroplasty. 2010;25:1170.e11-1170.e13.
242. Cordtz J, Jensen JS. Disseminated Ureaplasma urealyticum infection in a hypo-gammaglobulinaemic renal transplant patient. Scand J Infect Dis. 2006;38:1114-1117.
243. Asmar BI, Andresen J, Brown WJ. Ureaplasma urealyticum arthritis and bacteremia in agammaglobulinemia. Pediatr Infect Dis J. 1998;17: 73-76.
244. Goldenberg RL, Andrews WW, Goepfert AR, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol. 2008;198:43.e1-5.
245. Singh J, Arrieta A, Lang DJ. Neonate with chronic meningitis and hydrocephalus. Pediatr Infect Dis J. 2003;22:1025-1026, 1030-1031.
246. Garland SM, Murton LJ. Neonatal meningitis caused by Ureaplasma urealyticum. Pediatr Infect Dis J. 1987;6:868-870.
247. Xie X, Zhang J. Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. FEMS Microbiol Lett. 2006;259:181-186.